The use of liposomal amphotericin B in the treatment of neutropenia‐associated fungal infections: efficacy and cost‐effectiveness

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Haematology

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.1999.1249f.xPMID 10050732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study

  1999cited by this paper
• Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

  1998cited by this paper
• Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells

  1998cited by this paper
• Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes.

  1998influential reference
• Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor‐α concentration

  1997cited by this paper
• Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells.

  1997influential reference
• Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

  1997cited by this paper
• Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.

  1997cited by this paper
• In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations.

  1996cited by this paper
• DNA damage induced by tumour necrosis factor-α in L929 cells is mediated by mitochondrial oxygen radical formation

  1995cited by this paper
• Evans' syndrome, myelofibrosis and systemic lupus erythematosus: Role of procollagens in myelofibrosis

  1995cited by this paper
• Granulocyte-macrophage colony-stimulating factor expression by human fibroblasts is both upregulated and subsequently downregulated by interleukin-1.

  1995cited by this paper
• Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway.

  1993cited by this paper
• Antibodies against terminal galactosyl α(1–3) galactose epitopes in patients with idiopathic myelofibrosis

  1993cited by this paper
• Cost-Effectiveness Analysis of Treatment with Liposomal Amphotericin B versus Conventional Amphotericin B in Organ or Bone Marrow Transplant Recipients with Systemic Mycoses

  1992cited by this paper
• Idiopathic myelofibrosis: historical review, diagnosis and management.

  1991cited by this paper
• PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA

  1989cited by this paper
• RED CELL APLASIA IN MYELOFIBROSIS

  1989cited by this paper
• Proposals for the classification of the myelodysplastic syndromes

  1982cited by this paper
• In vitro interactions of PGE and cAMP with murine and human erythroid precursors.

  1980cited by this paper

• Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.

  2003cites this paper
• Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B

  2002cites this paper
• Supportive care in hematologic malignancies: hematopoietic growth factors, infections, transfusion therapy.

  2000cites this paper
• Supportive care in hematological malignancies: hematopoietic growth factors, infections, transfusion therapy.

  1999cites this paper
• Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient.

  1999cites this paper
• Hematopoietic growth factors: American Society of Clinical Oncology utilization review

  year unknowncites this paper